Search results
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 2 days agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 5 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 1 day agoThis was the first research project conducted to evaluate the immunity induced by the Pfizer...
Europe Strengthens Future Disease Defense
Medscape· 1 day agoA network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease...
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Benzinga· 5 days agoOptions are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and ...
Risk of uveitis recurrence higher in year after COVID vaccination
Center for Infectious Disease Research and Policy· 7 hours agoThe odds of the condition were increased among recipients of all 4 vaccines studied: Pfizer,...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 2 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
MedWatch Digest: A booster is better at promoting immunity — and more
WGN Chicago via Yahoo News· 4 days agoImmunity to COVID still wanes, but people were protected for double the time following the booster...
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
Motley Fool via Yahoo Finance· 7 days agoThe Stock Advisor service has more than quadrupled the return... 15, 2024 Keith Speights has...
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoOperator: Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results...
